Skip to main content
. 2009 Dec 18;98(3):385–393. doi: 10.1007/s11060-009-0090-3

Fig. 2.

Fig. 2

Responses to MTX monotherapy. CR complete response, PD progressive disease, PR partial response, MR mixed response, SD stable disease